These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 17851846

  • 1. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
    Hallqvist A, Rylander H, Björk-Eriksson T, Nyman J.
    Acta Oncol; 2007; 46(7):969-74. PubMed ID: 17851846
    [Abstract] [Full Text] [Related]

  • 2. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS, McCarley DL, Zlotecki RA.
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 4. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct 01; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 5. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 6. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033
    [Abstract] [Full Text] [Related]

  • 7. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
    Schild SE, Bonner JA, Hillman S, Kozelsky TF, Vigliotti AP, Marks RS, Graham DL, Soori GS, Kugler JW, Tenglin RC, Wender DB, Adjei A.
    J Clin Oncol; 2007 Jul 20; 25(21):3124-9. PubMed ID: 17634491
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 9. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May 27; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
    Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):943-51. PubMed ID: 15234027
    [Abstract] [Full Text] [Related]

  • 11. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B, Milicić B, Acimović L, Milisavljević S.
    J Clin Oncol; 2005 Oct 01; 23(28):6873-80. PubMed ID: 16192579
    [Abstract] [Full Text] [Related]

  • 12. Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients.
    Jeremić B, Miličić B, Milisavljevic S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1157-63. PubMed ID: 21640518
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
    Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):342-50. PubMed ID: 15890573
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 01; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

  • 15. [Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group].
    Isobe T, Fukuoka M, Negoro S, Sugiura T, Kawahara M, Kudoh S, Araki J, Nakagawa K, Yokozaki M, Yamakido M, Ariyoshi Y.
    Gan To Kagaku Ryoho; 2000 Jul 01; 27(8):1091-6. PubMed ID: 10945001
    [Abstract] [Full Text] [Related]

  • 16. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):807-11. PubMed ID: 7860392
    [Abstract] [Full Text] [Related]

  • 17. Limited-disease small-cell lung cancer.
    Zimmermann FB, Bamberg M, Molls M, Jeremic B.
    Semin Surg Oncol; 2003 Feb 15; 21(3):156-63. PubMed ID: 14508848
    [Abstract] [Full Text] [Related]

  • 18. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M.
    Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer.
    Yee D, Halperin R, Hanson J, Nijjar T, Butts C, Smylie M, Reiman T, Roa W.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):466-73. PubMed ID: 16563653
    [Abstract] [Full Text] [Related]

  • 20. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D, Bremer RH, Koppe F, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Pitz C, Simons J, ten Velde G, Dohmen J, Snoep G, Boersma L, Verschueren T, van Baardwijk A, Dehing C, Pijls M, Minken A, Lambin P.
    Radiother Oncol; 2006 Sep 01; 80(3):307-12. PubMed ID: 16949169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.